일회용 의료기기 시장 예측(-2030년) : 디바이스, 디바이스 클래스, 소재, 용도별

The global disposable medical device market is projected to reach 144.85 billion in 2030, growing from USD 113.95 billion in 2025, at a CAGR of 4.9% during the forecast period.

The growth of the market is driven by rising concerns over hospital-acquired infections (HAIs), increasing surgical procedures, and the need for cost-effective, single-use solutions. Additionally, the growing elderly population, rising prevalence of chronic diseases, and strong demand for home healthcare support this trend. Regulatory emphasis on infection control, materials, and manufacturing technology advancements fuels global market expansion.

"By device type, the drug delivery devices segment is projected to grow at the highest CAGR during the forecast period."

The drug delivery devices segment is experiencing significant growth driven by the increasing prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, which are significantly boosting the demand for disposable syringes, needles, and infusion sets for long-term therapy management. Additionally, the global rise in vaccination programs, especially post-pandemic, has accelerated the adoption of single-use drug delivery systems to reduce the risk of contamination and enhance patient safety. The growing preference for home-based care and self-administration of injectable drugs also supports this growth, alongside technological advancements, such as prefilled syringes and auto-injectors that offer greater convenience and compliance. Moreover, regulatory push for infection prevention and disposables' cost-effectiveness further reinforces this segment's rapid expansion.

"The plastic-based segment is projected to grow at the highest CAGR during the forecast period."

The plastic-based segment is projected to witness the fastest growth during the forecast period. The growth is due to the cost-effectiveness, lightweight nature, high versatility, and ease of mass production offered by plastic-based materials. Plastics like polyethylene, polypropylene, and PVC are widely used for manufacturing a broad range of disposable devices, such as syringes, catheters, and surgical instruments. Additionally, advancements in biocompatible and recyclable plastics support sustainability trends, further fueling growth in this segment.

"By class of device, the class II segment is projected to grow at the highest CAGR during the forecast period."

The growth of the class II segment is driven by the widespread use of class II medical devices in essential medical procedures, especially in infection prevention and chronic disease management. These devices, such as surgical gloves, catheters, infusion sets, and diagnostic tools, balance safety and regulatory requirements, which makes them faster to market compared to class III devices. Additionally, the rising number of hospital admissions, outpatient procedures, and home healthcare setups has significantly boosted the demand for these moderately regulated devices. Moreover, post-pandemic infection control protocols and the global push for safe, single-use medical solutions continue accelerating the adoption of class II disposable devices.

"By end user, the homecare setting segment is projected to grow at the highest CAGR during the forecast period."

The projected growth of the home care setting during the forecast period is due to the increasing preference for home-based treatment, especially among the elderly and patients with chronic illnesses. Additionally, the rising cost of hospital care has further encouraged a shift toward more affordable home care solutions. Technological advancements have led to the development of compact, user-friendly, and safe disposable devices, such as insulin pens, wound dressings, and portable diagnostic tools. Moreover, greater awareness of people regarding health management and improved patient education empower individuals to manage their conditions independently at home, further fueling this segment's growth.

"Asia Pacific is projected to grow at the highest CAGR during the forecast period."

The growth of the disposable medical devices market in Asia Pacific is driven by rapid urbanization and an expanding middle-class population with increased access to healthcare services, boosting the demand for affordable and efficient medical solutions. Governments in India, China, and Southeast Asia are investing heavily in healthcare infrastructure and expanding insurance coverage, which, in turn, supports higher usage of disposable devices in hospitals and clinics. Additionally, the growing burden of chronic diseases, rising awareness of infection prevention, and an aging population are amplifying the need for single-use medical products. A strong medical manufacturing base and cost-effective production capabilities make the region a hub for domestic consumption and global supply of disposable medical devices.

A breakdown of the primary participants (supply-side) is provided below:

• By Company Type: Tier 1 - 45%, Tier 2 - 20%, and Tier 3 - 35%
• By Designation: C-level Executives - 35%, Directors - 25%, and Others - 40%
• By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Latin America - 10%, Middle East & Africa - 5%

The prominent players in the disposable medical device market include Johnson & Johnson (US), Baxter. (US), BD (US), Cardinal Health, Inc. (US), Abbott (US), Medtronic (Ireland), Solventum (US), Boston Scientific Corporation (US), Stryker Corporation (US), Teleflex Incorporated (US), B Braun SE. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Merit Medical Systems. (US), Alcon Inc. [Switzerland], Medline Industries, Inc. (US), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (US), STERIS. (US), Integra LifeSciences Holdings Corporation (US), Coloplast (Denmark), Kirwan Surgical Products, LLC (US), Owens & Minor, Inc. (US), Aspen Surgical Products, Inc. (US), and Paul Hartmann AG (Germany).

Research Coverage:

The report analyzes the disposable medical device market. It aims to estimate its size and future growth potential based on device type, device class, material, application, end user, and region. It covers a competitive analysis of key players and studies their company profiles, product/service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall disposable medical device market and its subsegments. It will help stakeholders understand the competitive landscape, gain more insights, and position their businesses better to plan suitable go-to-market strategies. The report will also help stakeholders understand the market pulse and provide information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Market Dynamics: Analysis of key drivers (Need for Infection Prevention & Cross-contamination Control, Growing Volume of Surgical and Minimally Invasive Procedures, Technological Innovations and Sustainable Alternatives, Regulatory Support and Guidelines), restraints (High Cumulative Costs for Bulk Procurement of Disposables, Advancements in Sterilization and Reprocessing Technologies), opportunities (Innovation in Sustainable Materials, Expansion in Emerging Markets & Underserved Regions), and challenges (Environmental Concerns and Regulatory Scrutiny on Medical Waste)
• Market Penetration: Extensive information on product portfolios offered by the major players in the global disposable medical device market
• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global disposable medical device market
• Market Development: Thorough knowledge and analysis of profitable markets by device type, class of device, material, application, end user, and region
• Market Diversification: Comprehensive information about newly launched consumable products, expanding markets, current advancements, and investments in the global disposable medical device market
• Competitive Assessment: Thorough evaluation of the market share, growth plans, product and service offerings, and capacities of the major competitors in the global disposable medical device market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.2.2 MARKETS COVERED
  • 1.2.3 YEARS CONSIDERED
• 1.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
• 2.3 GROWTH FORECAST
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 KEY INDUSTRY INSIGHTS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT
• 2.8 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DISPOSABLE MEDICAL DEVICE MARKET OVERVIEW
• 4.2 ASIA PACIFIC DISPOSABLE MEDICAL DEVICE MARKET, BY APPLICATION AND COUNTRY
• 4.3 DISPOSABLE MEDICAL DEVICE MARKET: DEVELOPED VS. EMERGING ECONOMIES
• 4.4 DISPOSABLE MEDICAL DEVICE MARKET, BY COUNTRY
• 4.5 DISPOSABLE MEDICAL DEVICE MARKET: REGIONAL MIX

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Infection prevention & cross-contamination control
    • 5.2.1.2 Growing surgical volumes and minimally invasive procedures
    • 5.2.1.3 Technological innovations and sustainable alternatives
    • 5.2.1.4 Regulatory support and guidelines
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cumulative costs for large-volume users
    • 5.2.2.2 Advancements in sterilization methods and reprocessing technologies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Innovation in sustainable materials
    • 5.2.3.2 Expansion in emerging markets and underserved regions
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Environmental concerns and regulatory scrutiny of medical waste
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ADVANCEMENTS IN MATERIAL SCIENCE AND SUSTAINABLE DESIGN
  • 5.3.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN DISPOSABLE MEDICAL DEVICE MARKET
  • 5.3.3 OUTSOURCING OF DISPOSABLE MEDICAL DEVICE SERVICES
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Biodegradable/Biopolymer materials
    • 5.4.1.2 IoMT-enabled smart disposables
  • 5.4.2 ADJACENT TECHNOLOGIES
    • 5.4.2.1 3D printing (additive manufacturing)
    • 5.4.2.2 Wearable sensors
  • 5.4.3 COMPLEMENTARY TECHNOLOGIES
    • 5.4.3.1 Sterilization technologies
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.1.1 Barriers to entry
    • 5.5.1.2 Brand loyalty and trust
    • 5.5.1.3 Demand for compact, cost-effective, and non-invasive devices
    • 5.5.1.4 Poor financing environment
  • 5.5.2 THREAT OF SUBSTITUTES
    • 5.5.2.1 Sustainability & environmental concerns
    • 5.5.2.2 Growth of reusable and hybrid devices
    • 5.5.2.3 Availability of alternatives
  • 5.5.3 BARGAINING POWER OF SUPPLIERS
    • 5.5.3.1 Raw material dependency and volume demand
    • 5.5.3.2 Role of contract manufacturing organizations (CMOs)
    • 5.5.3.3 Regulatory & compliance constraints
    • 5.5.3.4 Innovation vs. commoditization
  • 5.5.4 BARGAINING POWER OF BUYERS
    • 5.5.4.1 Price sensitivity and bulk procurement
    • 5.5.4.2 Regulatory and quality expectations
    • 5.5.4.3 Low switching cost
    • 5.5.4.4 Growth of centralized procurement models
  • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.5.1 Standardized product offerings
    • 5.5.5.2 Overlapping target customers
    • 5.5.5.3 Cost efficiency and scale as differentiators
    • 5.5.5.4 Low exit barriers
• 5.6 REGULATORY LANDSCAPE
  • 5.6.1 REGULATORY FRAMEWORK
    • 5.6.1.1 North America
      • 5.6.1.1.1 US
      • 5.6.1.1.2 Canada
    • 5.6.1.2 Europe
    • 5.6.1.3 Asia Pacific
      • 5.6.1.3.1 Japan
      • 5.6.1.3.2 China
      • 5.6.1.3.3 India
  • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.7 PRICING ANALYSIS
  • 5.7.1 AVERAGE SELLING PRICE RANGE FOR DISPOSABLE MEDICAL DEVICES, BY DEVICE AND KEY PLAYERS, 2022-2024
  • 5.7.2 AVERAGE SELLING PRICE RANGE, BY REGION, 2022-2024
• 5.8 VALUE CHAIN ANALYSIS
• 5.9 KEY CONFERENCES AND EVENTS IN 2025-2026
• 5.10 PATENT ANALYSIS
  • 5.10.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTIONS FOR DISPOSABLE MEDICAL DEVICE MARKET
  • 5.10.2 LIST OF MAJOR PATENTS, JANUARY 2022-JUNE 2025
• 5.11 SUPPLY CHAIN ANALYSIS
• 5.12 ECOSYSTEM ANALYSIS
• 5.13 TRADE ANALYSIS
  • 5.13.1 IMPORT DATA FOR HS CODE 9018, 2020-2024
  • 5.13.2 EXPORT DATA FOR HS CODE 9018, 2020-2024
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 ADJACENT MARKETS FOR DISPOSABLE MEDICAL DEVICES
• 5.16 UNMET NEEDS/END USER EXPECTATIONS IN DISPOSABLE MEDICAL DEVICE MARKET
• 5.17 IMPACT OF GEN AI IN DISPOSABLE MEDICAL DEVICE MARKET
• 5.18 INVESTMENT AND FUNDING SCENARIO
• 5.19 IMPACT OF 2025 US TARIFFS
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES
    • 5.19.5.1 Hospitals and clinics
    • 5.19.5.2 Ambulatory surgical centers
    • 5.19.5.3 Home care settings

6 DISPOSABLE MEDICAL DEVICE MARKET, BY DEVICE TYPE

• 6.1 INTRODUCTION
• 6.2 DRUG DELIVERY DEVICES
  • 6.2.1 SYRINGES
    • 6.2.1.1 Growing demand for safe injection practices, mass immunization programs, and rising chronic conditions to drive market
  • 6.2.2 NEEDLES
    • 6.2.2.1 Increasing focus on injection safety, rising chronic disease burden, and hospital-acquired infection control to drive market
  • 6.2.3 IV CATHETERS
    • 6.2.3.1 Increased procedural volume, safety mandates, and infection prevention to drive market
  • 6.2.4 INFUSION SETS
    • 6.2.4.1 Growth in chronic disease management, inpatient therapies, and home care fuels infusion to drive demand
  • 6.2.5 PREFILLED FLUSH SYRINGES
    • 6.2.5.1 Focus on infection prevention, workflow efficiency, and catheter maintenance to propel adoption of disposable prefilled flush syringes
  • 6.2.6 DISPOSABLE NEBULIZER KITS
    • 6.2.6.1 Rising respiratory disease burden, infection control mandates, and outpatient therapy to fuel demand for disposable nebulizer kits
  • 6.2.7 NASAL SPRAY DEVICES
    • 6.2.7.1 Convenience, dose accuracy, and expanding intranasal drug delivery applications to fuel demand for disposable nasal spray devices
  • 6.2.8 INHALERS
    • 6.2.8.1 Rise in respiratory disease prevalence and demand for infection-free, portable treatment to drive growth
• 6.3 SURGICAL & PROCEDURAL INSTRUMENTS
  • 6.3.1 STAPLERS
    • 6.3.1.1 Rising adoption in minimally invasive and outpatient surgeries to drive market
  • 6.3.2 FORCEPS & SCALPELS
    • 6.3.2.1 Enhanced infection control and growing demand in emergency settings to fuel growth
  • 6.3.3 SUCTION TUBES
    • 6.3.3.1 Rising focus on infection control and operative efficiency to drive demand for disposable suction tubes
  • 6.3.4 CURETTES
    • 6.3.4.1 Growing preference for single-use instruments in OB/GYN, ENT, and dermatological procedures to drive market
  • 6.3.5 TROCARS & CANNULAS
    • 6.3.5.1 Increasing laparoscopic procedures and infection control mandates to fuel demand for disposable trocars & cannulas
  • 6.3.6 ELECTROCAUTERY PENCILS
    • 6.3.6.1 Rise in surgical volume and stricter infection control standards to bolster demand for disposable electrocautery pencils
  • 6.3.7 HEMOSTATIC CLIPS
    • 6.3.7.1 Increasing use of disposable hemostatic clips in minimally invasive procedures to prevent bleeding
  • 6.3.8 GRASPERS
    • 6.3.8.1 Growing demand for cost-effective and infection-safe instruments in laparoscopic and general surgeries to drive market
• 6.4 CATHETERS & TUBES
  • 6.4.1 URINARY CATHETERS
    • 6.4.1.1 Increasing urinary incontinence cases and focus on infection control to drive demand
  • 6.4.2 GLOBAL VOLUME ANALYSIS OF URINARY CATHETERS, 2023-2030 (THOUSAND UNITS)
  • 6.4.3 CENTRAL VENOUS CATHETERS
    • 6.4.3.1 Increasing adoption in critical care & infection-control driven protocols to fuel market
  • 6.4.4 GLOBAL VOLUME ANALYSIS OF CENTRAL VENOUS CATHETERS, 2023-2030 (THOUSAND UNITS)
  • 6.4.5 NASOGASTRIC TUBES
    • 6.4.5.1 Clinical versatility, infection control protocols, and demand from critical care units to drive market
  • 6.4.6 FEEDING TUBES
    • 6.4.6.1 Rising geriatric population, chronic conditions, and shift toward home nutrition support to fuel market
  • 6.4.7 ENDOTRACHEAL TUBES
    • 6.4.7.1 Rising critical care procedures and infection prevention measures to drive demand
• 6.5 PERSONAL PROTECTIVE EQUIPMENT (PPE)
  • 6.5.1 GLOVES
    • 6.5.1.1 Rising infection control measures, surgical volumes, and hygiene protocols to drive market expansion
  • 6.5.2 FACE MASKS
    • 6.5.2.1 Rising emphasis on infection control, airborne disease prevention, and occupational safety to fuel market growth
  • 6.5.3 GOWNS & CAPS
    • 6.5.3.1 Stringent infection control guidelines and pandemic-driven protocols to boost adoption of single-use protective apparel
• 6.6 DIAGNOSTIC & TESTING DEVICES
  • 6.6.1 LATERAL FLOW ASSAYS
    • 6.6.1.1 Rise in point-of-care diagnostics and infectious disease surveillance to drive market expansion
  • 6.6.2 GLOBAL VOLUME ANALYSIS OF LATERAL FLOW ASSAYS, 2023-2030 (THOUSAND UNITS)
  • 6.6.3 BLOOD GLUCOSE STRIPS
    • 6.6.3.1 Rising diabetes burden and shift toward home-based monitoring to drive demand
  • 6.6.4 GLOBAL VOLUME ANALYSIS OF BLOOD GLUCOSE STRIPS, 2023-2030 (THOUSAND UNITS)
  • 6.6.5 SWABS
    • 6.6.5.1 Rising demand from diagnostic testing, infection surveillance, and point-of-care settings to drive growth
  • 6.6.6 SPECIMEN CONTAINERS
    • 6.6.6.1 Rising emphasis on diagnostic accuracy, infection control, and regulatory compliance to drive growth
  • 6.6.7 DISPOSABLE THERMOMETERS
    • 6.6.7.1 Infection prevention, cost-effectiveness, and point-of-care efficiency to drive growth
  • 6.6.8 ECG ELECTRODES
    • 6.6.8.1 Rising cardiac monitoring needs & infection prevention measures to drive demand
• 6.7 RESPIRATORY & ANESTHESIA DEVICES
  • 6.7.1 OXYGEN MASKS
    • 6.7.1.1 Rising incidence of respiratory disorders & emergency care utilization to boost market
  • 6.7.2 NASAL CANNULAS
    • 6.7.2.1 Growing respiratory patient pool and home oxygen therapy to drive demand
  • 6.7.3 HEAT MOISTURE EXCHANGERS
    • 6.7.3.1 Critical role in airway management and ICU ventilation to drive market
  • 6.7.4 ANESTHESIA CIRCUITS
    • 6.7.4.1 Rising focus on cross-contamination prevention and or efficiency to drive market
  • 6.7.5 DISPOSABLE LARYNGOSCOPE BLADES
    • 6.7.5.1 Rising focus on cross-contamination control & emergency preparedness to drive demand
• 6.8 UROLOGY & GYNECOLOGY DEVICES
  • 6.8.1 DISPOSABLE VAGINAL SPECULUMS
    • 6.8.1.1 Rising gynecological screening, infection control, and patient-centric care to drive market
  • 6.8.2 SINGLE-USE HYSTEROSCOPY CATHETERS
    • 6.8.2.1 Rising preference for minimally invasive gynecological procedures & infection control to propel demand
  • 6.8.3 URETHRAL DILATORS
    • 6.8.3.1 Rising preference for minimally invasive gynecological procedures & infection control to propel demand
• 6.9 OPHTHALMIC & ENT DEVICES
  • 6.9.1 OPHTHALMIC SURGICAL BLADES
    • 6.9.1.1 Precision in microsurgery and focus on sterility drive market
  • 6.9.2 ENT SUCTION TIPS
    • 6.9.2.1 Rising surgical volumes, infection control protocols, and pediatric ENT procedures to propel market
  • 6.9.3 DISPOSABLE OTOSCOPE SPECULA
    • 6.9.3.1 Rising infection prevention measures and pediatric applications to drive market
• 6.10 OTHER DEVICES

7 DISPOSABLE MEDICAL DEVICE MARKET, BY DEVICE CLASS

• 7.1 INTRODUCTION
• 7.2 CLASS I
  • 7.2.1 POSSESS MINIMUM POTENTIAL TO HARM USERS
• 7.3 CLASS II
  • 7.3.1 REQUIRE REGULATORY CONTROLS TO ENSURE SAFETY AND EFFICACY
• 7.4 CLASS III
  • 7.4.1 ESSENTIAL IN PREVENTING HEALTH IMPAIRMENT OR POTENTIAL UNREASONABLE RISK OF ILLNESS OR INJURY

8 DISPOSABLE MEDICAL DEVICE MARKET, BY MATERIAL

• 8.1 INTRODUCTION
• 8.2 PLASTIC BASED
  • 8.2.1 SHIFT TOWARD PLASTICS FOR AFFORDABILITY, DESIGN FLEXIBILITY, AND INFECTION CONTROL TO DRIVE DEMAND
• 8.3 METAL BASED
  • 8.3.1 DEMAND FOR PRECISION, STRENGTH, AND SINGLE-USE COMPLIANCE TO DRIVE GROWTH
• 8.4 RUBBER BASED
  • 8.4.1 WIDESPREAD USE IN SEALING, DAMPING, AND BIOCOMPATIBLE APPLICATIONS TO DRIVE DEMAND
• 8.5 OTHER MATERIALS

9 DISPOSABLE MEDICAL DEVICE MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 PUBLIC HOSPITALS
  • 9.2.2 PRIVATE HOSPITALS
• 9.3 AMBULATORY SURGICAL CENTERS
  • 9.3.1 GROWING PREFERENCE FOR DISPOSABLE MEDICAL DEVICES IN AMBULATORY SETTINGS DRIVEN BY INFECTION CONTROL, OPERATIONAL EFFICIENCY, AND REGULATORY COMPLIANCE
• 9.4 HOMECARE SETTING
  • 9.4.1 RISING DEMAND FOR SELF-ADMINISTERED AND REMOTE CARE TO FUEL GROWTH
• 9.5 OTHER END USERS

10 DISPOSABLE MEDICAL DEVICE MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 GENERAL SURGERY
  • 10.2.1 INCREASING USE OF DISPOSABLE INSTRUMENTS IN OPERATING ROOMS TO REDUCE INFECTIONS AND IMPROVE EFFICIENCY
• 10.3 RESPIRATORY
  • 10.3.1 INCREASING RESPIRATORY DISEASE BURDEN, INFECTION CONTROL MEASURES, AND AT-HOME VENTILATION TO FUEL DEMAND
• 10.4 UROLOGY
  • 10.4.1 RISING GERIATRIC POPULATION, INFECTION PREVENTION PROTOCOLS, AND AT-HOME CARE MODELS TO DRIVE DEMAND
• 10.5 GYNECOLOGY
  • 10.5.1 GROWING EMPHASIS ON INFECTION CONTROL, AMBULATORY CARE, AND TECHNOLOGICAL SIMPLICITY TO DRIVE DEMAND
• 10.6 WOUND CARE
  • 10.6.1 RISING SURGICAL PROCEDURES AND DIABETIC ULCERS TO DRIVE DEMAND
• 10.7 DIAGNOSTIC & MONITORING
  • 10.7.1 RISING DEMAND FOR CHRONIC DISEASE MANAGEMENT AND HOME-BASED MONITORING TO DRIVE MARKET
• 10.8 CARDIOVASCULAR
  • 10.8.1 RISING CARDIOVASCULAR DISEASE BURDEN AND TECHNOLOGICAL INNOVATIONS TO DRIVE DEMAND
• 10.9 INFECTION CONTROL
  • 10.9.1 EMPHASIS ON HAIS PREVENTION, REGULATORY PRESSURE, AND PANDEMIC PREPAREDNESS TO DRIVE GROWTH
• 10.10 ICU/EMERGENCY
  • 10.10.1 RISING ACUTE CARE DEMAND & INFECTION PREVENTION PROTOCOLS TO ACCELERATE DISPOSABLE DEVICE USE IN CRITICAL SETTINGS
• 10.11 OTHER APPLICATIONS

11 DISPOSABLE MEDICAL DEVICE MARKET, BY REGION

• 11.1 INTRODUCTION
  • 11.1.1 GLOBAL VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS)
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK
  • 11.2.2 NORTH AMERICA: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS)
  • 11.2.3 US
    • 11.2.3.1 Growth fueled by regulatory push, rising chronic diseases, and infection control mandates
  • 11.2.4 CANADA
    • 11.2.4.1 Stringent infection control regulations and chronic disease burden to propel growth
• 11.3 ASIA PACIFIC
  • 11.3.1 MACROECONOMIC OUTLOOK
  • 11.3.2 ASIA PACIFIC: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS)
  • 11.3.3 JAPAN
    • 11.3.3.1 Aging population, infection control norms, and technological innovation to fuel growth
  • 11.3.4 CHINA
    • 11.3.4.1 Aging population, regulatory push, and local manufacturing to fuel growth
  • 11.3.5 INDIA
    • 11.3.5.1 Rising focus on infection control, government schemes, and domestic manufacturing to drive growth
  • 11.3.6 AUSTRALIA
    • 11.3.6.1 Growing emphasis on infection control, aging population, and local manufacturing push to drive growth
  • 11.3.7 SOUTH KOREA
    • 11.3.7.1 Regulatory streamlining, digital healthcare infrastructure, and local production to drive growth
  • 11.3.8 REST OF ASIA PACIFIC
• 11.4 EUROPE
  • 11.4.1 MACROECONOMIC OUTLOOK
  • 11.4.2 EUROPE: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS)
  • 11.4.3 GERMANY
    • 11.4.3.1 Strong regulatory standards, aging population, and digital health integration to drive adoption
  • 11.4.4 UK
    • 11.4.4.1 Stringent infection control regulations, NHS procurement, and sustainability initiatives to drive growth
  • 11.4.5 FRANCE
    • 11.4.5.1 Regulatory alignment, rising infection control standards, and shift toward ambulatory care to drive market
  • 11.4.6 SPAIN
    • 11.4.6.1 Rising hospital admissions, infection control regulations, and public-private healthcare investment to fuel growth
  • 11.4.7 ITALY
    • 11.4.7.1 Aging population, healthcare reforms, and infection prevention measures to accelerate market growth
  • 11.4.8 REST OF EUROPE
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK
  • 11.5.2 LATIN AMERICA: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS)
  • 11.5.3 BRAZIL
    • 11.5.3.1 Public health expansion, domestic manufacturing push, and infection control measures to drive growth
  • 11.5.4 MEXICO
    • 11.5.4.1 Regulatory reform, healthcare expansion, and public health investments to drive market growth
  • 11.5.5 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK
  • 11.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS)
  • 11.6.3 GCC COUNTRIES
    • 11.6.3.1 Kingdom of Saudi Arabia (KSA)
      • 11.6.3.1.1 Healthcare system transformation and regulatory focus to drive demand for disposable medical device types
    • 11.6.3.2 UAE
      • 11.6.3.2.1 Growing ICU procedures, chronic disease therapy needs, and infection control mandates to drive disposable CVC adoption
    • 11.6.3.3 Rest of GCC Countries
  • 11.6.4 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
  • 12.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN DISPOSABLE MEDICAL DEVICE MARKET
• 12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
• 12.3 MARKET SHARE ANALYSIS
  • 12.3.1 DISPOSABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYERS, 2024 (GLOBAL)
  • 12.3.2 DISPOSABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYERS, 2024 (US)
• 12.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.4.1 STARS
  • 12.4.2 EMERGING LEADERS
  • 12.4.3 PERVASIVE PLAYERS
  • 12.4.4 PARTICIPANTS
  • 12.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.4.5.1 Company footprint
    • 12.4.5.2 Regional footprint
    • 12.4.5.3 Device type footprint
    • 12.4.5.4 Material footprint
    • 12.4.5.5 Device class footprint
    • 12.4.5.6 Application footprint
• 12.5 COMPANY EVALUATION MATRIX, STARTUPS/ SMES, 2024
  • 12.5.1 PROGRESSIVE COMPANIES
  • 12.5.2 RESPONSIVE COMPANIES
  • 12.5.3 DYNAMIC COMPANIES
  • 12.5.4 STARTING BLOCKS
  • 12.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.5.5.1 List of key startups/SMEs
    • 12.5.5.2 Competitive benchmarking of key startups/SMEs
• 12.6 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6.1 FINANCIAL METRICS
  • 12.6.2 COMPANY VALUATION
• 12.7 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 12.8 R&D ASSESSMENT OF KEY PLAYERS
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 JOHNSON & JOHNSON
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product approvals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 BD
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 CARDINAL HEALTH
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
      • 13.1.3.3.2 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 MEDTRONIC
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 ABBOTT
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 SOLVENTUM
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
      • 13.1.6.3.2 Other developments
  • 13.1.7 BOSTON SCIENTIFIC CORPORATION
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product approvals
  • 13.1.8 BAXTER
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product approvals
      • 13.1.8.3.2 Other developments
  • 13.1.9 TERUMO CORPORATION
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
      • 13.1.9.3.2 Expansions
  • 13.1.10 NIPRO CORPORATION
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Expansions
  • 13.1.11 TELEFLEX INCORPORATED
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches
      • 13.1.11.3.2 Deals
  • 13.1.12 STRYKER
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product approvals
  • 13.1.13 FRESENIUS KABI AG
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product approvals
      • 13.1.13.3.2 Deals
      • 13.1.13.3.3 Other developments
  • 13.1.14 MEDLINE INDUSTRIES, INC.
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
  • 13.1.15 MERIT MEDICAL SYSTEMS.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Deals
  • 13.1.16 B. BRAUN SE
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Product launches and approvals
      • 13.1.16.3.2 Deals
      • 13.1.16.3.3 Other developments
  • 13.1.17 ALCON INC.
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products offered
    • 13.1.17.3 Recent developments
      • 13.1.17.3.1 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 ICU MEDICAL, INC.
  • 13.2.2 STERIS
  • 13.2.3 INTEGRA LIFESCIENCES CORPORATION
  • 13.2.4 COLOPLAST CORP.
  • 13.2.5 PAUL HARTMANN AG
  • 13.2.6 OWENS & MINOR.
  • 13.2.7 KIRWAN SURGICAL PRODUCTS, LLC
  • 13.2.8 ASPEN SURGICAL PRODUCTS, INC.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 CUSTOMIZATION OPTIONS
  • 14.2.1 DEVICE TYPE ANALYSIS
  • 14.2.2 GEOGRAPHIC ANALYSIS
  • 14.2.3 COMPANY INFORMATION
  • 14.2.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
  • 14.2.5 COUNTRY-LEVEL VOLUME ANALYSIS BY CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES
  • 14.2.6 BY DEVICE TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
  • 14.2.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
• 14.3 RELATED REPORTS
• 14.4 AUTHOR DETAILS